InvestorsHub Logo

BioChica

04/17/14 3:38 PM

#26665 RE: sts66 #26664

KOWA is a very diverse company, with multiple products. I doubt that they need Amarin to survive. It's is good to see them teamed up with Amarin though! We should see some improvement in script numbers by June-July I hope. Pitvaspa or Vaspitva sound like a good combination Therapy. ;).

go seek

04/17/14 6:53 PM

#26671 RE: sts66 #26664

Kowa will no longer sell Lipofen when they add Vascepa.